239 related articles for article (PubMed ID: 8259687)
1. [Immunohistochemical differentiation of granulosa cell tumors and undifferentiated ovarian cancers].
Kohlberger P
Wien Klin Wochenschr; 1993; 105(20):589-90. PubMed ID: 8259687
[No Abstract] [Full Text] [Related]
2. [Immunohistochemical differentiation of granulosa cell tumors and ovarian cancers].
Gitsch G; Kohlberger P; Kölbl H; Krepler R; Breitenecker G
Gynakol Rundsch; 1991; 31 Suppl 2():370-2. PubMed ID: 1790983
[No Abstract] [Full Text] [Related]
3. Serous papillary adenocarcinoma and adult granulosa cell tumor in the same ovary. An unusual case.
Ozbey C; Erdogan G; Pestereli HE; Simsek T; Karaveli S
APMIS; 2005 Oct; 113(10):713-5. PubMed ID: 16309432
[TBL] [Abstract][Full Text] [Related]
4. Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumor.
Rabban JT; Gupta D; Zaloudek CJ; Chen LM
Gynecol Oncol; 2006 Dec; 103(3):1164-8. PubMed ID: 17034837
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas.
Gitsch G; Kohlberger P; Hanzal E; Kölbl H; Breitenecker G
Arch Gynecol Obstet; 1991; 249(4):173-7. PubMed ID: 1665684
[TBL] [Abstract][Full Text] [Related]
6. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of ras p21 oncoprotein in undifferentiated and well-differentiated epithelial carcinomas of the human ovary.
Kuwashima Y; Shisa H; Uehara T; Kurosumi M; Kobayashi Y; Tanuma J; Shiromizu K; Matsuzawa M; Kishi K
Anticancer Res; 1995; 15(6B):2847-50. PubMed ID: 8669877
[TBL] [Abstract][Full Text] [Related]
8. Ovarian tumors. A review.
Scully RE
Am J Pathol; 1977 Jun; 87(3):686-720. PubMed ID: 194486
[No Abstract] [Full Text] [Related]
9. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
[TBL] [Abstract][Full Text] [Related]
11. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features.
Ota T; Gilks CB; Longacre T; Leung PC; Auersperg N
Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889
[TBL] [Abstract][Full Text] [Related]
12. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
[TBL] [Abstract][Full Text] [Related]
13. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
[TBL] [Abstract][Full Text] [Related]
14. [Experiences with the tumor markers Ca 125 and plasma ribonuclease in ovarian cancer].
Lücke R; Benz R; Kraus H
Geburtshilfe Frauenheilkd; 1987 Dec; 47(12):846-9. PubMed ID: 3481339
[TBL] [Abstract][Full Text] [Related]
15. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
16. Composite mucinous and granulosa cell tumor of the ovary.
Kushida Y; Haba R; Kadota K; Doi T; Ishikawa M; Hirakawa E; Kira M
Pathol Int; 2005 Dec; 55(12):797-801. PubMed ID: 16287496
[TBL] [Abstract][Full Text] [Related]
17. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
19. [Inhibin and ovarian cancer].
Burger HG; Baillie A; Drummond AE; Healy DL; Jobling T; Mamers P; Robertson DM; Susil B; Cahir N; Shen Y; Verity K; Fuller PJ; Groome NP; Findlay JK
Vopr Onkol; 1999; 45(4):369-73. PubMed ID: 10532093
[TBL] [Abstract][Full Text] [Related]
20. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]